Although not experimentally validated, the fimsbactins are predicted to bind siderocalin [55], which would effectively inactivate them in vivo and would be consistent with our findings that disruption to fimsbactins biosynthesis does not significantly impact the outcome of infection (Fig 9). This evidence concerns the gene LCN2 and infection.